Skip to main content
A

AimaLabs

AIMA Labs develops artificial intelligence software for the automated analysis of peripheral blood smears. This technology provides healthcare professionals with a reliable and efficient tool for the precise identification and classification of cellular components. The platform aims to facilitate timely diagnosis of hematological conditions, improving laboratory throughput and supporting point-of-care management.

Founded 2024350+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Manual blood smear analysis is a time-consuming process that requires skilled personnel, leading to potential inconsistencies and delays in diagnosing hematological disorders. The need for expert microscopists can be a bottleneck, especially in point-of-care settings and during off-hours when specialists may not be readily available.

Solution

AIMA Labs offers an AI-powered software solution that automates the analysis of peripheral blood smears, enhancing the efficiency and accuracy of hematological diagnostics. The software uses advanced image analysis algorithms and neural networks to identify, classify, and enumerate blood cells, including erythrocytes, leukocytes, and thrombocytes. By automating the interpretation of blood smear morphology, the platform ensures consistency in diagnostic interpretation and reduces the reliance on manual review. The system streamlines the workflow from image capture to report generation, providing clinicians with rapid and reliable results for informed decision-making.

Target Audience

The primary target audience includes healthcare professionals in laboratories and hospitals seeking to improve the efficiency and accuracy of blood smear analysis, as well as point-of-care facilities requiring rapid diagnostic results.

Features

  • Automated identification and segmentation of erythrocytes, leukocytes, and thrombocytes from digital images of blood smears
  • Neural networks trained to classify red cells based on size variance, hemoglobin concentration, and morphological abnormalities
  • Specialized algorithms for detecting and categorizing leukocytes into neutrophils, lymphocytes, monocytes, eosinophils, and basophils based on nuclear morphology
  • Cytoplasmic analysis to match identified nuclear types with corresponding cytoplasmic characteristics
  • Automated enumeration of thrombocytes for diagnosing thrombocytopenic or thrombotic states
  • Generation of comprehensive reports detailing the microscopic analysis of blood cells
  • Streamlined workflow from sample collection and image capture to final reporting
This profile is AI-generated and may contain inaccuracies.